Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

pembrolizumab 308Nivolumab 159Carboplatin 158Cisplatin 140Cyclophosphamide 135Paclitaxel 128Magnetic Resonance Spectroscopy 98Specimen Handling 95Radiotherapy 92Gemcitabine 88Dexamethasone 86Biopsy 81Ipilimumab 81Docetaxel 78Doxorubicin 76Rituximab 70Etoposide 69durvalumab 61Lenalidomide 60Radiation 60Prednisone 59atezolizumab 59Taxes 58Pemetrexed 57Bevacizumab 54fludarabine 54olaparib 52Cytarabine 51Vincristine 51Fluorouracil 48

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × 68Ga-DKFZ-PSMA-11 × 1 year × Clear all
NCT05547386 2025-07-18

68Ga-PSMA-11 PET/CT Screening Prior to 177Lu-PSMA-617 Therapy for Patients With Metastatic Castrate Resistant Prostate Cancer

Mayo Clinic

Phase 3 Completed
163 enrolled 3 charts
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡